ELAPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ELAPHARMA
Largest movements
- Receivables after one year +€55,000
up €55,000 (+32.4%), from €170,000 to €225,000
- Deferred charges and accrued income -€3,278
down €3,278 (-36.9%), from €8,884 to €5,606
- Receivables within one year +€2,634
up €2,634 (+86.8%), from €3,034 to €5,668
of which Trade receivables: +€4,845
- Profit (loss) carried forward +€35,928
up €35,928 (+26.8%), from €133,890 to €169,818
- Tax, wage and social debts +€14,736
up €14,736 (+46.7%), from €31,551 to €46,287
- Other debts +€6,931
new in 2025: €6,931
- Trade debts -€3,162
down €3,162 (-21.8%), from €14,480 to €11,317
- Gross operating margin +€37,542
up €37,542 (+227.3%), from €16,516 to €54,058
- Taxes +€7,028
up €7,028 (+194.0%), from €3,622 to €10,651
- Financial charges +€2,498
up €2,498 (+46.4%), from €5,384 to €7,882
- Other operating charges +€903
up €903 (+21.0%), from €4,300 to €5,203
- Financial income +€555
up €555 (+11.0%), from €5,051 to €5,606
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €181,920 | €236,353 | +€54,433 | +29.9% |
| Current assets | 29/58 | €181,920 | €236,353 | +€54,433 | +29.9% |
| Amounts receivable after more than one year | 29 | €170,000 | €225,000 | +€55,000 | +32.4% |
| Other amounts receivable | 291 | €170,000 | €225,000 | +€55,000 | +32.4% |
| Amounts receivable within one year | 40/41 | €3,034 | €5,668 | +€2,634 | +86.8% |
| Trade receivables | 40 | €823 | €5,668 | +€4,845 | +588.5% |
| Other amounts receivable | 41 | €2,211 | - | -€2,211 | |
| Cash at bank and in hand | 54/58 | €2 | €79 | +€78 | +5039.6% |
| Deferred charges and accrued income | 490/1 | €8,884 | €5,606 | -€3,278 | -36.9% |
| Total equity and liabilities | 10/49 | €181,920 | €236,353 | +€54,433 | +29.9% |
| Equity | 10/15 | €134,390 | €170,318 | +€35,928 | +26.7% |
| Contributions | 10/11 | €500 | €500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €133,890 | €169,818 | +€35,928 | +26.8% |
| Amounts payable | 17/49 | €47,530 | €66,035 | +€18,505 | +38.9% |
| Amounts payable within one year | 42/48 | €46,030 | €64,535 | +€18,505 | +40.2% |
| Trade debts | 44 | €14,480 | €11,317 | -€3,162 | -21.8% |
| Suppliers | 440/4 | €14,480 | €11,317 | -€3,162 | -21.8% |
| Taxes, remuneration and social security | 45 | €31,551 | €46,287 | +€14,736 | +46.7% |
| Taxes | 450/3 | €31,551 | €46,287 | +€14,736 | +46.7% |
| Other amounts payable | 47/48 | - | €6,931 | +€6,931 | |
| Accrued charges and deferred income | 492/3 | €1,500 | €1,500 | = | 0.0% |
| Other operating charges | 640/8 | €4,300 | €5,203 | +€903 | +21.0% |
| Gross operating margin | 9900 | €16,516 | €54,058 | +€37,542 | +227.3% |
| Operating profit (loss) | 9901 | €12,216 | €48,855 | +€36,639 | +299.9% |
| Financial income | 75/76B | €5,051 | €5,606 | +€555 | +11.0% |
| Recurring financial income | 75 | €5,051 | €5,606 | +€555 | +11.0% |
| Financial charges | 65/66B | €5,384 | €7,882 | +€2,498 | +46.4% |
| Recurring financial charges | 65 | €5,384 | €7,882 | +€2,498 | +46.4% |
| Profit (loss) for the period before taxes | 9903 | €11,883 | €46,579 | +€34,696 | +292.0% |
| Income taxes | 67/77 | €3,622 | €10,651 | +€7,028 | +194.0% |
| Profit (loss) for the period | 9904 | €8,261 | €35,928 | +€27,668 | +334.9% |
| Profit (loss) for the period to be appropriated | 9905 | €8,261 | €35,928 | +€27,668 | +334.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.